Ergoteles’s Invivyd IVVD Stock Holding History

Ergoteles’s Portfolio IVVD Stock Details IVVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,006	Closed	-$15K	–	1494
2022 Q4	$15K	Buy	+10,006	New	+$27.8K	﹤0.01%	1356
2022 Q3	–	Sell	-50,100	Closed	-$164K	–	1749
2022 Q2	$164K	Buy	+50,100	New	+$157K	﹤0.01%	1389

Other funds holding IVVD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Ergoteles's IVVD Position: Q1 2023 in Review

Ergoteles sold out of Invivyd (IVVD) in Q1 2023, closing a stake of 10,006 shares — an estimated $15K sold.

Ergoteles first reported a position in IVVD in Q2 2022 and held it in 2 quarters. The position peaked at $164K in Q2 2022. 70 funds tracked by Wall St. Rank hold IVVD as of Q1 2023.

Ergoteles reported no remaining Invivyd position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 10,006 Invivyd shares in Q1 2023, an estimated $15K.
Ergoteles first reported a position in Invivyd in Q2 2022 and held it in 2 quarters.
Ergoteles's Invivyd position peaked at $164K in Q2 2022.
70 funds tracked by Wall St. Rank held Invivyd as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.